Company
United StatesSarah Larson, M.D., Los Angeles, CA – FDA Inspections
Inspection records and compliance data for Sarah Larson, M.D. in Los Angeles, California. 1 FDA inspection on record, last inspected March 08, 2023.
Company Profile
This profile covers Sarah Larson, M.D. based in Los Angeles, California, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected March 8, 2023.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 8, 2023 | NAI | Human Drugs · Bioresearch Monitoring | 1199654 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Apinya B. Vutikullird, D.O.
Optimer Pharmaceuticals Inc
VA Greater Los Angeles Healthcare System IRB #B
Rajagopal Sunder
Marshall B. Ketchum University IRB #1
Palm Drug, Inc. dba Palm Medical Supplies
ASA Universal Inc. dba: Sonage
Edward Garon, M.D., Clinical Investigator
Pouya Dayani, MD
Memorial Research Medical Clinic
Company Information
Name
Sarah Larson, M.D.
FEI Number
3025922191
Address
10833 Le Conte Ave, Los Angeles, California 90095, United States
Country
United States
ID: 8302830c-2b3b-479b-adce-1b9ded7e6e64